Podcast

The Ups and Downs of Biosimilar Development

Dr Paul Rhyne, Chief Scientific Officer and Vice President Bioanalytical Operations

Biosimilar KOL, Dr Paul Rhyne, Chief Scientific Officer and Vice President of Bioanalytical Operations Biologics Development Services (BDS), provides and an overview of the current state of biosimilars and their global impact.

LISTEN TO THE PODCAST!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Biosimilar Development? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: